Journal of Medicinal Food · 2011 · 113 citations · 45 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyMolecular OncologyMolecular PharmacologyMedicinal PlantsPharmacodynamics Of Anticancer AgentsCancer Cell Proliferation InhibitionFlavonoid GlycosidesFruit FlavonoidsGlycogen Synthase Kinase 3 RegulationNuclear Factor Kappa B Modulation
Pancreatic cancer studies have shown that inhibition of glycogen synthase kinase-3β (GSK-3β) leads to decreased cancer cell proliferation and survival by abrogating nuclear factor κB (NFκB) activity. In this investigation, various citrus compounds, including flavonoids, phenolic acids, and limonoids, were individually investigated for their inhibitory effects on GSK-3β by using a luminescence assay. Of the 22 citrus compounds tested, the flavonoids luteolin, apigenin, and quercetin had the highest inhibitory effects on GSK-3β, with 50% inhibitory values of 1.5, 1.9, and 2.0 μM, respectively. Molecular dockings were then performed to determine the potential interactions of each citrus flavonoid with GSK-3β. Luteolin, apigenin, and quercetin were predicted to fit within the binding pocket of GSK-3β with low interaction energies (-76.4, -76.1, and -84.6 kcal·mol(-1), respectively) and low complex energies (-718.1, -688.1, and -719.7 kcal·mol(-1), respectively). Our results indicate that several citrus flavonoids inhibit GSK-3β activity and suggest that these have potential to suppress the growth of pancreatic tumors.
45
Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
Amer A. Beg, William C. Sha, Roderick T. Bronson et al. · Nature · 1995 · 1.8K citations